{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSBPO-18020 RM Policy for the Management of Allergy Status 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "POLICY FOR THE MANAGEMENT OF ALLERGY STATUS"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSBPO- 18020"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff involved in the prescribing, dispensing and administration of medication"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "31/01/2019"
                    },
                    {
                        "text": "Review Due Date:"
                    },
                    {
                        "text": "30/01/2022"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Building a Safer NHS for Patients- Improving Medication Safety. Department of Health. March 2004. Standardising wristbands improves patient safety. NPSA Safer Practice Notice 24. July 2007."
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "(Insert no. of Standard) Regulation 12 - Safe care and treatment"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "MSB Pharmacy"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Joanna Jedlinska \u2013 Lead Pharmacist Admissions (SUH site)"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "MEHT BTUH SUH"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Medicines Optimisation Committee (SUH) Medicines Management Committee (BTUH) Medicines Management and Safety Group (MEHT)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "09/11/2018 09/11/2018 09/11/2018"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Evelyn Allen, Director of Pharmacy"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "21/03/2018"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Control Management Group"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "22/01/2019"
                    },
                    {
                        "text": "Executive and Clinical Directors"
                    },
                    {
                        "text": "Date: February 2018"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Trust Intranet/ Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSBPO-18020 RM Policy for the Management of Allergy Status 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 7,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "SUH ePrescribing Team"
                    },
                    {
                        "text": "SUH Pharmacy Department"
                    },
                    {
                        "text": "21/3/18"
                    },
                    {
                        "text": "SUH Pharmacy Admissions team"
                    },
                    {
                        "text": "SUH Pharmacy Department"
                    },
                    {
                        "text": "21/3/18"
                    },
                    {
                        "text": "Maria Richards"
                    },
                    {
                        "text": "Principal Pharmacist, Acute Medicine MEHT"
                    },
                    {
                        "text": "16/10/18"
                    },
                    {
                        "text": "MEHT Pharmacy Management Team"
                    },
                    {
                        "text": "MEHT Pharmacy Department"
                    },
                    {
                        "text": "16/10/18"
                    },
                    {
                        "text": "Fatemeh Leedham"
                    },
                    {
                        "text": "BTUH Pharmacy Head of Department"
                    },
                    {
                        "text": "02/11/18"
                    },
                    {
                        "text": "Agnes Nyantaki, Claire Fitzgerald"
                    },
                    {
                        "text": "Lead Pharmacists - Women & Children (BTUH & MEHT)"
                    },
                    {
                        "text": "25/10/18"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text)"
                    },
                    {
                        "text": "All Medicines Management Policies on all sites Incident and Serious Incident Policy (or equivalent policy) Patient Identification Policy & Procedure (or equivalent policy) Resuscitation Council (UK): Anaphylaxis Algorithm Anaphylaxis Treatment and Investigation: Laboratory Investigation of Anaphylaxis (or equivalent policy) Policy for the Management of PAS Alerts (or equivalent policy)"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Joanna Jedlinska \u2013 Lead Pharmacist Admissions"
                    },
                    {
                        "text": "Amalgamation of MSB documents: RM14 (SUH), CP/GU/00251 (BTUH), Penicillin Allergy Guide (MEHT). Definitions added for Allergy status, NKDA, NKA. JAC ePrecribing added into chapter 3 and 6 (for SUH)."
                    },
                    {
                        "text": "31/01/2019"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 7
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions ................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and Responsibilities ........................................................................................ 5"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2 Role & Responsibilities of Individuals within the Trust ........................................ 6"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Determining Allergy Status ........................................................................................... 8"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "No Known Allergies ...................................................................................................... 8"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Neonate Allergy Status Documentation ........................................................................ 8"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Allergies Unknown ........................................................................................................ 8"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Known allergies and sensitivities .................................................................................. 9  Patient Identification Wristbands .................................................................................. 9 11 Training Requirements ............................................................................................... 9 12 Monitoring and Audit .................................................................................................. 9 13 Approval and Implementation ................................................................................. 10 14 References ................................................................................................................ 10 15 Quality Impact Assessment ..................................................................................... 10 16 Equality Impact Assessment ................................................................................... 10"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy for the Management of Allergy Status / MSBPO-18020 / version 1.0"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A number of incidents reported locally, nationally and internationally, illustrate serious harm, in some cases fatal, has occurred to patients who have been prescribed, dispensed and administered drugs to which they have had a pre-existing allergic response."
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This policy covers all patients admitted to hospital either as an elective or emergency admission. Any patient admitted on an electronic prescribing (EP) system or issued with a paper Drug Prescription Chart and Administration Record (AKA: \u201cdrug chart\u201d) should have the \u201callergy status\u201d section of the chart filled in."
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Purpose:"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 1,
                "text": "To ensure we manage patients with a known allergy / adverse drug reaction (ADR) to medication, in an efficient and structured manner, to minimise risk to the patient. Serious harm has occurred when patients have been prescribed / dispensed / administered drugs, to which they have a pre-existing allergy or known serious reaction. This policy is necessary to ensure that medication allergy and adverse drug reaction (ADR) status of all patients is confirmed, as soon as possible following admission."
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients also have allergies and sensitivities to other substances such as surgical equipment (e.g. latex) and foods. It is important that these are treated the same as any drug allergy / sensitivity to avoid exposure to the patient whilst under our care."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This policy seeks to give a clear and robust system on how to identify patients' allergy / ADR status, how and where to document this, use of the Trust wristband and the responsibilities of health care professionals. It is recommended in the Department of Health report, Building a Safer NHS for Patients- Improving Medication Safety March 2004 that Trusts should implement a written standard for the documentation of drug allergies."
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "type": "table",
            "sequence_num": 29,
            "data": {
                "num_rows": 11,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "Allergy"
                    },
                    {
                        "text": "Drug allergy is a hypersensitivity condition of the body against a certain drug manifesting most frequently in various skin reactions, bronchospasm and oedema, while the most severe form of allergy is anaphylactic shock, which is an acute life- threatening allergic reaction connected with oedema of the respiratory tract."
                    },
                    {
                        "text": "Allergy Status"
                    },
                    {
                        "text": "A defined health record of a patients current allergies or sensitivities or a clear statement that there are no such allergies or sensitivities. This will be dated and state the nature of any such allergies."
                    },
                    {
                        "text": "Sensitivity"
                    },
                    {
                        "text": "Drug sensitivity is typically an intolerance, which is often a milder, non-immune-mediated reaction, and does not depend on prior exposure."
                    },
                    {
                        "text": "ADR"
                    },
                    {
                        "text": "Adverse Drug Reaction. A response to a drug that is noxious and unintended and occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for modification of physiological function\" (World Health Organisation definition)."
                    },
                    {
                        "text": "NKDA"
                    },
                    {
                        "text": "No known drug allergies"
                    },
                    {
                        "text": "NKA"
                    },
                    {
                        "text": "No known allergies"
                    },
                    {
                        "text": "MUSAG"
                    },
                    {
                        "text": "Medicines Use and Safety Action Group (or equivalent on each site)"
                    },
                    {
                        "text": "NPSA"
                    },
                    {
                        "text": "National Patient Safety Agency"
                    },
                    {
                        "text": "PNMF"
                    },
                    {
                        "text": "Professional Nursing and Midwifery Forum (or equivalent on each site)"
                    },
                    {
                        "text": "MOC/MMC"
                    },
                    {
                        "text": "Medicines Optimisation Committee / Medicines Management Committee (depending on hospital site/ or equivalent) This will be merged as one msb Medicines Optimisation Committee during lifetime of this policy."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and Responsibilities"
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Roles and Responsibilities within the Trust (Committees) Site Clinical Governance Committee (CGC) (or equivalent) Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Receive exception reporting from MOC/MMC and determine appropriate action with directorates/divisions as appropriate"
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Site/MSB Medicines Optimisation Committee (MOC) / Medicines Management"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Committee (MMC) (or equivalent)"
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the effective implementation, use and timely review of this policy."
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where necessary the MOC/MMC will escalate concerns to the Site Director of Nursing or Medical Director as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Site Medicines Use and Safety Action Group (MUSAG) (or equivalent)"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitoring this policy through incident reports"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reporting and exception reporting any relevant audits and action plans to MOC/MMC in an appropriate and timely manner."
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Site Professional Nursing and Midwifery Forum (PNMF) (or equivalent) Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any Nursing or Midwifery professional issues related to the administration of medicines and allergy status is managed and actions taken."
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Following up any actions identified from audits undertaken to ward level."
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "Role & Responsibilities of Individuals within the Trust Duties Are:"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Chief Executive"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "As the Trust Accountable Officer has overall responsibility for:"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the MSB group of hospitals has robust, complete and up to date procedures in place to govern and guide activities so that legal and national requirements are met."
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Chief Nurse/Director of Nursing"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the system of recording allergy status and identification (as per this policy and relevant site policies) is maintained and measured in accordance with Trust governance arrangements"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Site Medical Director"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any Medical staff professional issues related to the prescribing of medicines and allergy status is managed and actions taken."
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Site Pharmacy Head of Department"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any Pharmacy staff or other allied health professional issues related to the prescribing of medicines and allergy status is managed and actions taken."
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Liaising with the relevant allied health professional lead, where appropriate, to facilitate this."
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Prescribers (including non-medial Prescribers), Administering staff (i.e. Registered Nurse/Midwife) and Registered Pharmacy staff"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Jointly responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Existing allergies & sensitivities:"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that any new patient has their allergy status documented on their drug chart (i.e. allergy and type of reaction caused, if known). This must also be documented in the patients' medical notes (i.e. in the appropriate place in the admission documentation/proforma)."
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Documenting on the ePrescribing drug chart the allergy status under \u201cPatient Allergy\u201d or double checking the existing information. Where paper drug charts are used, allergies should be documented in the allergy status box and the entry should be signed and dated with a bleep number."
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring allergies are clear and the type of reaction is recorded, and clarifying this"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "where needed without delay."
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 1,
                "text": "New allergies & sensitivities:"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Update the patient's drug chart and medical records with details of any allergy that occurs whilst they are an inpatient. The same applies if an existing allergy becomes apparent in the period after admission (i.e. via old notes etc.). The documentation must detail the type of reaction."
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Prescriber"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for (in addition to joint responsibilities above):"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that they consult the allergy status before prescribing any medication for a patient."
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure they do not prescribe any medication to a patient where the allergy status has not been documented unless the patient's clinical condition demands it."
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure the allergy status is always transcribed in full on all subsequent drug charts used during the patient's admission."
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 1,
                "text": "New allergies & sensitivities:"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring new allergies are transcribed onto the discharge summary with the type of reaction to inform the GP."
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Registered Nurse / Midwife"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for (in addition to joint responsibilities above):"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Existing allergies & sensitivities:"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that the patient's allergy status is documented in the relevant paperwork etc. where they are involved in the admission process."
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring each patient under their care has the appropriate wristband(s) attached in accordance with the Site Patient ID policy. Any patient with any documented allergy (drug /food/dressing etc.) should ensure that the patient has red ID wristbands attached as opposed to the standard white ones."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Confirming that any new patient under their care has their allergy status documented on their drug chart, and taking appropriate actions as detailed in this policy."
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Not administering any medication to a patient with no documented allergy status, either on the drug charts or in the medical notes (unless the patient's medical condition demands it). The appropriate documentation should be sought ASAP and updated by the registrant, where possible. Where a patient requires urgent medical attention any vital medication should be given, even if the allergy status of the patient is unknown."
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 1,
                "text": "New allergies & sensitivities:"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that a new set of red wristbands are issued to the patient and the white ones removed if a new allergy occurs. The same applies if an existing allergy becomes apparent in the period after admission (i.e. via old notes etc)."
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Pharmacy Staff"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Not supplying medication for an individual patient where the allergy status is not documented on the drug chart. Where a supply of medication is requested against a drug chart with no allergy status medical team or ward staff will be contacted in order to verify allergy status. The only exception to this is again for patients whose medical attention requires urgent treatment, and neonates."
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Making arrangement for confirming and documenting allergy status with the relevant medical team, if attending the ward."
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Supporting the accuracy of allergy status documentation as part of the medicines reconciliation process, including alerting prescribers and updating of documentation as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Determining Allergy Status"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Where possible the patient should be asked their allergy status. Where this is not a reliable source of information other sources should be consulted (please refer to the Site Policy for Medicines Reconciliation for a guide)."
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "JAC ePrescribing (SUH site only) will prompt the user every time the drug chart is accessed where allergy status is not documented."
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Appropriate sources of information include:"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Healthcare records"
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Previous prescription charts"
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient's relative or carer"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "text": "GP"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Summary care record (SCR)"
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "No Known Allergies"
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Patients with no known allergies must be endorsed with the statement \u201cNone Known\u201d or \u201cNo Known Allergies\u201d i.e. NKA."
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Where ePrescribing is used the \u2018No known drug allergies' button must be clicked on and therefore \u2018ticked'."
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "Where paper drug charts are used \u2018no known drug allergies', NKDA, NKA may be used in the allergy status box, signed and dated."
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Neonate Allergy Status Documentation"
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1 Neonates, by their nature, do not have any allergies at birth. Allergy status on drug charts must be annotated with NKDA/NKA or \u2018newborn'. This should then be updated as and if appropriate as per this policy."
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Allergies Unknown"
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "In patients where the allergy status is currently unavailable or unknown then a statement to this effect must be recorded. This must only be used where all reasonable attempts have been made at that time to establish allergy status, without success."
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Where JAC ePrescribing (SUH site) is used the \u201cDrug Allergy Status Undetermined\u201d button must be clicked on and therefore \u2018ticked'."
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "Where paper drug charts are used, \u201cTo Be Confirmed\u201d or \u201cUnknown At Present\u201d, must be documented, along with the date, in the allergy box."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "This must be followed up at the earliest opportunity, and allergy status updated with either the response for no known or known allergies/sensitivities."
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Known allergies and sensitivities"
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Patients with a known allergy must have this documented on the drug chart with the nature of the reaction also recorded."
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "The drug chart also calls for \u201csensitivities\u201d. This does therefore include drugs which may have caused an adverse effect i.e. diarrhoea, dizziness. These sensitivities may be significant enough to warrant avoiding a drug or drug group and must be recorded but it is vital to also record the nature of the reaction so that they can be dealt with accordingly."
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "Alternatively patients may have allergies to latex or shellfish. These allergies must also be recorded on the drug chart as overlooking them may have significant implications for patient safety."
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "The type of reaction must be documented. Some reactions may be manageable should the drug be required in future (as the only choice at that time). Alternatively the reaction may be life threatening and must never be prescribed for the patient."
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.5,
                "text": "In JAC ePrescribing (SUH site) allergies may be added from the patient allergy section. Drugs are prebuilt into a drop down list. Combination drugs are not listed. Therefore, where a patient is allergic to a combination product, all constituent drugs must be listed. The most common reactions are also provided in a drop down menu. Where \u2018Other' is selected, the type of reaction must be recorded on ePrescribing as an \u2018Allergic Reaction' note. JAC ePrescribing (SUH site) will automatically alert a prescriber with a warning should the drug be attempted to be prescribed at a later date. This MUST be actively overridden by the prescriber, therefore requiring additional thought before continuing."
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.6,
                "text": "Where paper charts are used, the type of reaction should be recorded next to the drug. The allergy status must be signed and dated."
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 1,
                "text": "10 Patient Identification Wristbands"
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.1,
                "text": "Allergies must not be written on any wristbands. The drug chart is the approved location for documenting allergies and sensitivities. All patients with any type of allergy/sensitivity (drug, food, dressing etc.) must wear RED colour wristbands."
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 1,
                "text": "11 Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 0,
                "text": "No specific training requirements."
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 1,
                "text": "12 Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "type": "table",
            "sequence_num": 122,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Non- compliance"
                    },
                    {
                        "text": "Incident Reporting"
                    },
                    {
                        "text": "Department of Pharmacy"
                    },
                    {
                        "text": "Ongoing"
                    },
                    {
                        "text": "Site Medicines Use and Safety Action Group (or"
                    },
                    {
                        "text": "Site Medicines Optimisation"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 123,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "equivalent) Site Clinical Governance Committee"
                    },
                    {
                        "text": "Committee / Site Medicines Management Committee (or equivalent)"
                    },
                    {
                        "text": "Presence of red patient wristband"
                    },
                    {
                        "text": "Nursing Dashboard"
                    },
                    {
                        "text": "Matrons within each Directorate/Division"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "Site Professional Nursing and Midwifery Forum"
                    },
                    {
                        "text": "Chief Nurse"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "13 Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This policy has been reviewed and approved by the Medicines Optimisation/Management Groups, overseen by pharmacy, across the msb group of hospitals. This will be implemented with immediate effect from its agreement date. This document will be available electronically on the Trust intranet. Advice and support on the implementation of this policy is available via the site department of pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 1,
                "text": "14 References"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Building a Safer NHS for Patients- Improving Medication Safety. Department of Health. March 2004."
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Standardising wristbands improves patient safety. NPSA Safer Practice Notice 24. July 2007."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 1,
                "text": "15 Quality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This policy has been the subject of a Quality Impact Assessment. The output of the assessment demonstrates that quality is not adversely impacted as a consequence of this policy"
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 1,
                "text": "16 Equality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This policy has been the subject of an Equality Impact Assessment. The output of the assessment demonstrates that no one as a consequence of this policy is placed at a disadvantage over others."
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy for the Management of Allergy Status / RM14 / v5"
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 134
        }
    ]
}